Company intelligence / Profile preview

EZMEMS

Ownership: Private
Development stage: Commercial

Overview

EZMEMS has developed a disruptive edge multi-sensing technology that enables real-time monitoring of multiple physical parameters within fluids. Their modular platform can be integrated into disposable medical devices or used throughout biotech/pharma production lines to improve efficiency, traceability, quality control, and safety. The technology supports high-performance data collection at the edge of IoT systems. No clinical trial results are applicable as this is a sensor/platform company.

Therapeutic areas: Other
Modalities: Multisensor platforms (for pressure, flow, temperature, turbidity, conductivity, pH)Disposable multisensors for medical and pharma products
Industry: Chemicals & Materials

Beyond the preview

Go deeper on EZMEMS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EZMEMS.

Explore the full profile